{"disease":{"id":"hypoplastic-mds","name":"hypoplastic mds"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05998408","title":"JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":145,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}